Natalia Kraeva Selected Research

Halothane (Fluothane)

1/2022	Variants in ASPH cause exertional heat illness and are associated with malignant hyperthermia susceptibility.
12/2020	A multi-dimensional analysis of genotype-phenotype discordance in malignant hyperthermia susceptibility.
1/2017	Skeletal Muscle Metabolic Dysfunction in Patients With Malignant Hyperthermia Susceptibility.
9/2015	Malignant hyperthermia testing in probands without adverse anesthetic reaction.
2/2014	Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
10/2013	Analysis of histomorphology in malignant hyperthermia-susceptible patients.
1/2013	CASQ1 gene is an unlikely candidate for malignant hyperthermia susceptibility in the North American population.
7/2010	A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Natalia Kraeva Research Topics

Disease

16	Malignant Hyperthermia 01/2022 - 07/2010
8	Contracture 01/2022 - 07/2010
3	Rhabdomyolysis 07/2017 - 11/2014
2	Heat Stress Disorders (Heat Cramp) 01/2022 - 11/2014
2	Muscular Diseases (Myopathy) 01/2020 - 02/2013
2	Muscle Weakness 01/2017 - 09/2015
2	Fatigue 01/2017 - 09/2015
1	Hyperglycemia 01/2020
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Muscle Rigidity 07/2017
1	Hyperthermia 07/2017
1	Tachycardia (Tachyarrhythmias) 07/2017
1	Channelopathies 10/2016
1	Type 1 Episodic Ataxia 10/2016
1	Central Core Myopathy (Central Core Disease) 02/2013

Drug/Important Bio-Agent (IBA)

8	Halothane (Fluothane)FDA Link 01/2022 - 07/2010
8	Anesthetics (Anesthetic Agents)IBA 01/2022 - 01/2013
8	Caffeine (No Doz)FDA LinkGeneric 01/2022 - 07/2010
8	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2020 - 02/2013
4	CalciumIBA 01/2021 - 01/2018
2	Creatine Kinase (Creatine Phosphokinase)IBA 07/2017 - 09/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 10/2016
1	Dantrolene (Dantrium)FDA LinkGeneric 09/2015
1	Neuromuscular Depolarizing AgentsIBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 07/2010
1	Sevoflurane (Ultane)FDA LinkGeneric 07/2010

Therapy/Procedure

3	Anesthesia 01/2019 - 07/2010
1	Resuscitation 01/2019
1	General Anesthesia 07/2017
1	Nephrectomy 07/2010